The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy. It has around 3,000 members, from 50 countries, practicing in more than 23 different specialty areas.
The Annual Meeting 2024 is taking place in Prague, Czech Republic, April 10-13.
Programme is available at this link on the ISHLT website.
All of the sessions are important and relevant for pulmonary hypertension patients as they address the overarching issues in the pre and post transplant surgery phases and new developments expected in the near future. Three symposia are dedicated specifically to pulmonary hypertension:
SYMPOSIUM 04: Come Together: Improving Survival in Pulmonary Arterial Hypertension
Primary Core Therapy: PVD | Primary Practice Area: Pulmonology
SYMPOSIUM 16: Controversies in Management of End-Stage Pulmonary Hypertension
Primary Core Therapy: PVD | Primary Practice Area: Pulmonology
SYMPOSIUM 43: A Hard Day’s Night: Challenges in Managing Group 2 and Group 3 PH
Primary Core Therapy: PVD | Primary Practice Area: Cardiology